Clinical and imaging observations in isolated sulfite oxidase deficiency

Parayil Sankaran Bindu1, Rita Christopher, Anita Mahadevan

  • 1Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bangalore, India. drpsbindu@yahoo.co.in

Insights

Isolated sulfite oxidase deficiency is a rare neurometabolic disorder. Early diagnosis through urine sulfite testing and genetic analysis is crucial for management and genetic counseling.

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Genetics

Background:

  • Isolated sulfite oxidase deficiency (ISOD) is a rare neurometabolic disorder.
  • ISOD clinically and radiologically mimics hypoxic ischemic encephalopathy.
  • This condition requires careful differentiation due to overlapping symptoms.

Observation:

  • Two pediatric patients, aged 14 months and 8 years, with ISOD were studied.
  • Both presented with severe neonatal-onset neurodevelopmental deficits including profound mental retardation, microcephaly, spastic quadriparesis, and intractable seizures.
  • Clinical presentation and brain imaging findings were documented.

Findings:

  • Diagnosis was confirmed by detecting elevated urinary sulfites and subsequent genetic analysis.
  • Brain MRI revealed progressive severe cystic leukomalacia, ulegyric cortical atrophy, and cerebellar hypoplasia in both patients.
  • Imaging findings correlated with the clinical severity and progression of the disease.

Implications:

  • Early and accurate diagnosis of ISOD is critical.
  • Prompt diagnosis allows for timely genetic counseling and the option of prenatal testing for affected families.
  • Understanding the natural history and imaging features aids in differentiating ISOD from other neurometabolic disorders.